Rapid Micro Biosystems is a medical devices business based in the US. Rapid Micro Biosystems shares (RPID) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.10 – an increase of 1.85% over the previous week. Rapid Micro Biosystems employs 193 staff and has a trailing 12-month revenue of around $26.2 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.10 |
|---|---|
| 52-week range | $0.58 - $1.34 |
| 50-day moving average | $0.97 |
| 200-day moving average | $0.88 |
| Wall St. target price | $8.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.12 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.15 from 2024-11-22
| 1 week (2024-11-19) | 4.55% |
|---|---|
| 1 month (2024-10-25) | 25.00% |
| 3 months (2024-08-26) | 36.71% |
| 6 months (2024-05-24) | 40.24% |
| 1 year (2023-11-24) | 9.52% |
|---|---|
| 2 years (2022-11-25) | -49.12% |
| 3 years (2021-11-26) | 13.15 |
| 5 years (2019-11-23) | N/A |
| Revenue TTM | $26.2 million |
|---|---|
| Gross profit TTM | $-8,540,000 |
| Return on assets TTM | -25.33% |
| Return on equity TTM | -45.62% |
| Profit margin | -184.93% |
| Book value | $1.93 |
| Market Capitalization | $47.8 million |
TTM: trailing 12 months
We're not expecting Rapid Micro Biosystems to pay a dividend over the next 12 months.
You may also wish to consider:
Rapid Micro Biosystems's shares were split on a 1:30 basis on 28 October 2010 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rapid Micro Biosystems shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Rapid Micro Biosystems shares which in turn could have impacted Rapid Micro Biosystems's share price.
Over the last 12 months, Rapid Micro Biosystems's shares have ranged in value from as little as $0.58 up to $1.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rapid Micro Biosystems's is 1.079. This would suggest that Rapid Micro Biosystems's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Rapid Micro Biosystems's beta into context you can compare it against those of similar companies.
Rapid Micro Biosystems, Inc. , a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.